Poster Presentation 2025 Joint Meeting of the COSA ASM and IPOS Congress

Getting the MOST out of follow-up: A Phase II randomized trial of nurse led telehealth follow-up including monitoring CA125 and patient reported outcomes using the MOST-S26 (Measure of Ovarian Symptoms and Treatment concerns) versus routine clinic based or telehealth follow-up, after completion of first line chemotherapy in patients with epithelial ovarian cancer (126288)

Paul A Cohen 1 , Andreas Obermair 2 , Val Gebski 3 , Madeleine T King 4 , Phyllis Butow 5 , Rachel Campbell 5 , Sanela Bilic 6 , Alison Brand 7 , Jim Codde 8 , Jeffrey Goh 9 , Angela Ives 10 , Andrew Kiberu 11 , Wanda Lawson 12 , Anne Mellon 13 , Orla McNally 14 , Tarek Meniawy 15 , Linda Mileshkin 16 , Rachael L Morton 17 , Penelope M Webb 18 , Michael Friedlander 19
  1. Department of Gynecological Oncology, King Edward Memorial Hospital, Perth, Australia
  2. Gynaecological Cancer Research, The University of Queensland, Brisbane, Queensland, Australia
  3. NHMRC Clinical Trials Centre, The University of Sydney, Sydney, New South Wales, Australia
  4. School of Psychology, Faculty of Science, The University of Sydney, Sydney, New South Wales, Australia
  5. Psycho-oncology Co-operative Research Group (PoCoG), School of Psychology, University of Sydney, Sydney, NSW, Australia
  6. St John of God Subiaco Hospital, Subiaco, Western Australia, Australia
  7. Department of Gynaecological Oncology, Westmead Hospital, Sydney, NSW, Australia
  8. Institute for Health Research, The University of Notre Dame Australia, Fremantle, Western Australia, Australia
  9. Department of Oncology, Royal Brisbane & Women’s Hospital, Herston, Queensland, Australia
  10. Medical School, The University of Western Australia, Perth, Western Australia, Australia
  11. St John of God Hospital, Bunbury, Western Australia, Australia
  12. Australia and New Zealand Gynaecological Oncology Group, Sydney, New South Wales, Australia
  13. Hunter New England Centre for Gynaecological Cancer, John Hunter Hospital, Newcastle, New South Wales, Australia
  14. Oncology and Dysplasia Unit, The Royal Women's Hospital, Melbourne, Victoria, Australia
  15. Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia
  16. Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
  17. NHMRC Clinical Trials Centre, The University of Sydney, Sydney, New South Wales, Australia
  18. Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
  19. Medical Oncology, Prince of Wales Hospital, Sydney, New South Wales, Australia
Publish consent withheld